People over age 45 should consider a daily dose of aspirin to protect against heart disease and cancer, researchers say.
Evidence builds that the health benefits of middle-aged and older "far outweighs" side effects after university.
Especially at a higher risk of these two big killers, people can take medication against the pain as a preventive medication.
The experts were addressing the Royal Society of Medicine, after a month search for Oxford University showed that taking 75 mg of aspirin per day for five years reduces the risk of bowel cancer by a quarter , and deaths from the disease by a third. A dose of 75 mg tablet is a standard quarter-OTC.
Previous studies have shown that small doses per day may reduce the risk of heart disease. Board members said that recent research is potentially "enormous importance".
intestinal or rectal cancer is the third most common form of the disease in Britain, where the diagnosis of 39 000 16 000 deaths a year. Research will also examine whether aspirin may have a preventive effect on other cancers.
Together, all cancers kill more than 150,000 lives in Britain each year, while cardiovascular disease for approximately 200,000 deaths.
Prof Peter Rothwell, Oxford neuroscientist who led the investigation, began taking a daily dose of aspirin itself. He said: "I think in five to 10 years will we be prescribing aspirin for all middle-aged, not only for known vascular benefits."
Evidence builds that the health benefits of middle-aged and older "far outweighs" side effects after university.
Especially at a higher risk of these two big killers, people can take medication against the pain as a preventive medication.
The experts were addressing the Royal Society of Medicine, after a month search for Oxford University showed that taking 75 mg of aspirin per day for five years reduces the risk of bowel cancer by a quarter , and deaths from the disease by a third. A dose of 75 mg tablet is a standard quarter-OTC.
Previous studies have shown that small doses per day may reduce the risk of heart disease. Board members said that recent research is potentially "enormous importance".
intestinal or rectal cancer is the third most common form of the disease in Britain, where the diagnosis of 39 000 16 000 deaths a year. Research will also examine whether aspirin may have a preventive effect on other cancers.
Together, all cancers kill more than 150,000 lives in Britain each year, while cardiovascular disease for approximately 200,000 deaths.
Prof Peter Rothwell, Oxford neuroscientist who led the investigation, began taking a daily dose of aspirin itself. He said: "I think in five to 10 years will we be prescribing aspirin for all middle-aged, not only for known vascular benefits."

Comments
Post a Comment